Drug intelligence / Profile preview

sodium gluconate + magnesium chloride + sodium acetate + potassium chloride + sodium chloride

Development stage
Unknown
Lead developer
Takeda
Modality
Small Molecules
Administration
Intravenous
01

Overview

**Sodium gluconate + magnesium chloride + sodium acetate + potassium chloride + sodium chloride** is a sterile, nonpyrogenic, isotonic intravenous multi-electrolyte solution marketed by Baxter as **PLASMA-LYTE A** and **PLASMA-LYTE 148**. It provides sodium, potassium, magnesium, chloride, acetate, and gluconate to restore extracellular fluid volume and electrolyte balance. Acetate and gluconate serve as metabolizable hydrogen-ion acceptors that support an alkalinizing effect. The solution is used intravenously as a source of water and electrolytes and as an alkalinizing agent, including for hydration, dehydration, and electrolyte replacement. PLASMA-LYTE A Injection pH 7.4 contains, per 100 mL, sodium chloride 526 mg, sodium gluconate 502 mg, sodium acetate trihydrate 368 mg, potassium chloride 37 mg, and magnesium chloride hexahydrate 30 mg.

Brand names
PLASMA-LYTE APLASMA-LYTE 148PLASMA-LYTE148PLASMA-LYTE-148
Other names
Multiple Electrolytes Injection Type 1 USP

Beyond the preview

Go deeper on sodium gluconate + magnesium chloride + sodium acetate + potassium chloride + sodium chloride.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on sodium gluconate + magnesium chloride + sodium acetate + potassium chloride + sodium chloride.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call